Comparative study of the influence of the levonorgestrel intra-uterine system and the GnRH analogues on cardiovascular risk markers in patients with endometriosis
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study compared how the levonorgestrel intrauterine system and GnRH analogues affect cardiovascular risk markers in patients with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2013
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2021
Cited by (4)
- Gonadotropin-releasing hormone analogues for endometriosis 2023
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2021
- Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery 2013
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis 2010
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK